Search

Your search keyword '"Ara, Takahide"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Ara, Takahide" Remove constraint Author: "Ara, Takahide" Database ScienceDirect Remove constraint Database: ScienceDirect
32 results on '"Ara, Takahide"'

Search Results

3. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT

4. CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

6. Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

7. Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors

9. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades

11. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation

13. Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group

14. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation

15. Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

19. Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

20. Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

23. 36 - Loss of Y-Chromosome before Allogeneic Hematopoietic Stem Cell Transplantation Influences on Relapse in Male Recipients with Female Donors

24. The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

32. Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Catalog

Books, media, physical & digital resources